InMed Pharmaceuticals Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INM research report →
Companywww.inmedpharma.com
InMed Pharmaceuticals Inc. , a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa.
- CEO
- Eric A. Adams Chem.
- IPO
- 2014
- Employees
- 13
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $2.91M
- P/E
- -0.66
- P/S
- 0.00
- P/B
- 0.95
- EV/EBITDA
- 0.19
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.16%
- Op Margin
- -1.50%
- Net Margin
- -1.49%
- ROE
- -72.72%
- ROIC
- -135.77%
Growth & Income
- Revenue
- $4.94M · 7.50%
- Net Income
- $-8,162,133 · -6.34%
- EPS
- $-8.36 · 58.49%
- Op Income
- $-7,917,995
- FCF YoY
- -11.03%
Performance & Tape
- 52W High
- $7.98
- 52W Low
- $0.57
- 50D MA
- $0.74
- 200D MA
- $1.40
- Beta
- 0.57
- Avg Volume
- 1.62M
Get TickerSpark's AI analysis on INM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 19, 25 | Johnson Shane Aaron | other | 8,500 |
| Dec 19, 25 | Lemerond Nicole | other | 1,750 |
| Dec 19, 25 | Klompas Neil A | other | 1,750 |
| Dec 19, 25 | Jagpal Netta | other | 18,000 |
| Dec 19, 25 | WOUDENBERG MICHAEL | other | 18,000 |
| Dec 19, 25 | Bathery John Steven | other | 1,750 |
| Dec 19, 25 | HSU ERIC C | other | 13,000 |
| Dec 19, 25 | ADAMS ERIC A | other | 35,000 |
| Dec 19, 25 | HULL ANDREW | other | 1,750 |
| Dec 15, 25 | HULL ANDREW | other | 14 |
Our INM Coverage
We haven't published any research on INM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate INM Report →